Announced Sat, 20 Jun · 17:23 IST
Sun Pharma to acquire 100% stake in Innovcare Lifesciences for Rs 271.2 Cr
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.4%1-day move
₹1840.50
prior close
₹1845.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.6-0.3-0.4-0.2+1.4+1.8+1.1+1.7+1.4+1.7+5.6+5.6——
Up moveDown movePending
AI summary
Sun Pharma to acquire 100% shares of Mumbai-based Innovcare Lifesciences for Rs 271.2 Crores in cash. Innovcare sells pharma drugs, nutraceutical and cosmeceutical products with FY25-26 revenue of Rs 94.06 Crores (up from Rs 86.09 Cr in FY24-25 and Rs 80.93 Cr in FY23-24). The deal is strategic to strengthen Sun Pharma's product portfolio. Not a related party transaction. Expected to complete by 31 July 2026. No regulatory approvals needed.
Likely market impact
Bolt-on acquisition adding about Rs 94 Cr revenue to portfolio. Cash deal of Rs 271 Cr is small relative to Sun Pharma's overall scale. Marginally positive.